Open AccessDiabetic Ketoacidosis and Related Events in the Canagliflozin Type 2 Diabetes Clinical Program
Author(s) -
Ngozi Erondu,
Mehul Desai,
Kirk Ways,
Gary Meininger
Publication year - 2015
Publication title -
diabetes care
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.636
H-Index - 363
eISSN - 1935-5548
pISSN - 0149-5992
DOI - 10.2337/dc15-1251
Subject(s) - canagliflozin , medicine , diabetic ketoacidosis , diabetes mellitus , type 1 diabetes , incidence (geometry) , type 2 diabetes , metabolic acidosis , adverse effect , ketoacidosis , population , acidosis , endocrinology , insulin , pediatrics , physics , environmental health , optics
This study assessed the incidence of serious adverse events of diabetic ketoacidosis (DKA) among patients with type 2 diabetes treated with canagliflozin.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom